<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Wed, 05 Aug 2026 11:45:56 -0400--><rss version="2.0">
    <channel>
        <title>ClearPoint Neuro, Inc. (CLPT) Press Releases</title>
        <link>https://ir.clearpointneuro.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/clearpointneuro/files/clearpoint_logo.png</url>
                <title>ClearPoint Neuro, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[ClearPoint Neuro Reports Second Quarter 2026 Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.clearpointneuro.com/news-events/press-releases/detail/1156/clearpoint-neuro-reports-second-quarter-2026-results</link>
                <pubDate>Mon, 03 Aug 26 16:05:00 -0400</pubDate>
                <guid>https://ir.clearpointneuro.com/news-events/press-releases/detail/1156/clearpoint-neuro-reports-second-quarter-2026-results</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.clearpointneuro.com/news-events/press-releases/detail/1155/clearpoint-neuro-congratulates-partner-aspen-neuroscience</link>
                <pubDate>Fri, 31 Jul 26 16:05:00 -0400</pubDate>
                <guid>https://ir.clearpointneuro.com/news-events/press-releases/detail/1155/clearpoint-neuro-congratulates-partner-aspen-neuroscience</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.clearpointneuro.com/news-events/press-releases/detail/1154/clearpoint-neuro-to-announce-second-quarter-2026-results</link>
                <pubDate>Tue, 21 Jul 26 16:05:00 -0400</pubDate>
                <guid>https://ir.clearpointneuro.com/news-events/press-releases/detail/1154/clearpoint-neuro-to-announce-second-quarter-2026-results</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.clearpointneuro.com/news-events/press-releases/detail/1153/clearpoint-neuro-enters-into-10-year-focused-ultrasound</link>
                <pubDate>Wed, 27 May 26 16:30:00 -0400</pubDate>
                <guid>https://ir.clearpointneuro.com/news-events/press-releases/detail/1153/clearpoint-neuro-enters-into-10-year-focused-ultrasound</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ClearPoint Neuro Reports First Quarter 2026 Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.clearpointneuro.com/news-events/press-releases/detail/1152/clearpoint-neuro-reports-first-quarter-2026-results</link>
                <pubDate>Wed, 13 May 26 16:05:00 -0400</pubDate>
                <guid>https://ir.clearpointneuro.com/news-events/press-releases/detail/1152/clearpoint-neuro-reports-first-quarter-2026-results</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.clearpointneuro.com/news-events/press-releases/detail/1151/clearpoint-neuro-announces-ce-marking-of-velocity-alpha-mr</link>
                <pubDate>Wed, 13 May 26 16:00:00 -0400</pubDate>
                <guid>https://ir.clearpointneuro.com/news-events/press-releases/detail/1151/clearpoint-neuro-announces-ce-marking-of-velocity-alpha-mr</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.clearpointneuro.com/news-events/press-releases/detail/1150/clearpoint-neuro-to-announce-first-quarter-2026-results-may</link>
                <pubDate>Wed, 29 Apr 26 16:05:00 -0400</pubDate>
                <guid>https://ir.clearpointneuro.com/news-events/press-releases/detail/1150/clearpoint-neuro-to-announce-first-quarter-2026-results-may</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.clearpointneuro.com/news-events/press-releases/detail/1149/clearpoint-neuro-announces-fda-clearance-of-the-velocity</link>
                <pubDate>Wed, 22 Apr 26 16:05:00 -0400</pubDate>
                <guid>https://ir.clearpointneuro.com/news-events/press-releases/detail/1149/clearpoint-neuro-announces-fda-clearance-of-the-velocity</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.clearpointneuro.com/news-events/press-releases/detail/1148/clearpoint-neuro-announces-canadian-approval-for-its</link>
                <pubDate>Mon, 20 Apr 26 16:05:00 -0400</pubDate>
                <guid>https://ir.clearpointneuro.com/news-events/press-releases/detail/1148/clearpoint-neuro-announces-canadian-approval-for-its</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.clearpointneuro.com/news-events/press-releases/detail/1147/clearpoint-neuro-reports-fourth-quarter-and-full-year-2025</link>
                <pubDate>Tue, 17 Mar 26 16:05:00 -0400</pubDate>
                <guid>https://ir.clearpointneuro.com/news-events/press-releases/detail/1147/clearpoint-neuro-reports-fourth-quarter-and-full-year-2025</guid>
                                                                            </item>
            </channel>
</rss>